April 2010

TABLE OF CONTENTS

Industry Layoffs: Recessionary Medicine That’s Worse Than the Disease

Derek G. Hennecke, MBA, unveils his latest 6-part series on business models and best practices for navigating the new normal.

 

Inhalation: Going Beyond Asthma!

Contributor Cindy H. Dubin talks with leading inhalation drug delivery companies and discovers the growing focus on COPD, diabetes, and vaccinations.

 

Perspectives in Oncology Drug Delivery

Frost & Sullivan Analyst Daniel Ruppar believes many companies are seeking interest in oncology as an area to provide revenue streams and product opportunities, and this sector has not only been a key area for start-up companies, but it has also increasingly become a talking point for Big Pharma as an area of investment and future value.

 

Drug Delivery Partnerships Exemplify Excellence, Value & Innovation

In this post-show wrap-up of the Drug Delivery Partnership Conference, contributor Cindy H. Dubin highlights the companies recognized for establishing successful relationships with their partners.

 

Biphasix^TM: A Topical Drug Delivery System to Deliver Large Molecules Into the Skin 

Praveen Kumar, MPharm, PhD; Angela Perry, MSc; Ravinderjit Batta, MPharm; and M. King, PhD; describe a topical drug delivery system that enables delivery into and, with adjustments to the formulation, through the skin of an extensive variety of small and large molecules.

 

DSM Biomedical: Providing Solutions for the Biopharma & Medical Device Industries

Drug Delivery Executive: Mr. Donato Di Biase, Business Director, talks about DSM Biomedical’s drug delivery business unit, what makes its technology unique, and what the future holds for the company.

 

NuSil Technology: Formulating Innovations to Meet Demands of Today, Tomorrow

Drug Delivery Executive: Brian Nash, NuSil’s VP of Marketing and Sales, discusses how his company has for more than 30 years advanced the standards for manufacturing silicone products, allowing it to offer an unparalleled consistency in its standard and custom formulations.

 

Ingredient-Specific Particle Sizing: Reducing Risk, Cutting Cost & Saving Time in Inhalable Formulation Development
Linda M. Batykefer, MBA, and Oksana V. Olkhovyk, PhD, explain how using wide-field Raman chemical imaging to obtain ingredient-specific particle size distribution information before clinical trials can help to save time and money for inhalation or nasal product development.

 

Fast-Dissolve Technology is an Easy Pill to Swallow for Chronic Pain

Contributor Cindy H. Dubin talks with Wilmington Pharmaceuticals about the benefits that fast-dissolve technology brings to pain management, offering a viable alternative to some hard-to-swallow oral dosage forms.

 

Analytical Testing Laboratories: Adapting & Responding to the Current Business Climate

Contributor Cindy H. Dubin interviews PPD’s Magdalena Mejillano, PhD, to learn about the company’s new Ireland-based analytical lab and how it is responding to the needs of US- and European-based Specialty Pharma companies in today’s economy.

 

DEPARTMENTS

 

Market News & Trends

 

Excipient Update

Combining HME & Solubilization: Soluplus^® – The Solid Solution

 

Attorney Review

Designing Your Generic Pharmaceutical Product: How Close to the Branded Product is Too Close?

 

Technology Showcase

 

External Delivery

Mr. Fix It

 

COVER

FEATURES